Published online February 16, 2009
PEDIATRICS Vol. 123 Supplement March 2009, pp. S199-S204 (doi:10.1542/peds.2008-2233K)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mattke, S.
Right arrow Articles by Lurie, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mattke, S.
Right arrow Articles by Lurie, N.
Related Collections
Right arrow Asthma
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SUPPLEMENT ARTICLE



Quality of Care for Childhood Asthma: Estimating Impact and Implications

Soeren Mattke, MD, DSca, Francisco Martorell, PhDb, Priya Sharma, BAa, Floyd Malveaux, MD, PhDc and Nicole Lurie, MD, MSPHa

a Rand Corp, Arlington, Virginia
b Rand Corp, Santa Monica, California
c Merck Childhood Asthma Network, Inc, Washington, DC

We conducted a review of 164 relevant publications to consolidate the evidence on gaps in the quality of asthma care, the impact of those gaps, and the costs and benefits of closing those gaps. Researchers used a wide variety of definitions for measures of quality asthma care, clinical and utilization end points, and disease severity. Gaps in care were most evident for pharmacologic treatment, particularly the underuse of inhaled corticosteroids, with median usage rates of 40%; however, in studies with large proportions of black subjects, the inhaled corticosteroid usage rate was only 32%, compared with 51% for nonminority populations. Studies on outcomes focused on emergency department visits, hospital admissions, and missed school days. Because only 6 studies included information on the costs of improving asthma care, no consensus estimates of the cost/benefit ratio for better asthma care could be derived. There was insufficient evidence in the literature for assessment of the impact of gaps in care and the costs of closing those gaps. More economic evaluations of the impact of gaps in asthma care and of interventions to improve asthma control are needed. Future research on gaps in asthma care and their impact must use standardized definitions for key variables such as disease severity and care utilization to allow comparisons across studies and building of an evidence base that is convincing for policy makers and purchasers of care.


Key Words: asthma • health care disparities • cost/benefit ratio

Abbreviations: ED—emergency department • HEDIS—Healthcare Effectiveness and Data Information Set • ICS—inhaled corticosteroid • NHLBI—National Heart, Lung, and Blood Institute


Accepted Nov 4, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
N. Lurie, H. E. Mitchell, and F. J. Malveaux
State of Childhood Asthma and Future Directions Conference: Overview and Commentary
Pediatrics, March 1, 2009; 123(Supplement_3): S211 - S214.
[Abstract] [Full Text] [PDF]